Authorized Generics’ Impact On Medicaid Pricing To Be Focus Of HHS Study
The HHS Inspector General will initiate a study in fiscal 2006 examining the effect of authorized generics on Medicaid drug pricing and rebates
The HHS Inspector General will initiate a study in fiscal 2006 examining the effect of authorized generics on Medicaid drug pricing and rebates